CSPI CRITICIZES EFIDAC/24, SOURCE OF LIFE 1993 AD CAMPAIGNS
This article was originally published in The Tan Sheet
CSPI CRITICIZES EFIDAC/24, SOURCE OF LIFE 1993 AD CAMPAIGNS at a Jan. 27 press conference to announce the recipients of the consumer group's Ninth Annual "Harlan Page Hubbard Lemon Awards" for "misleading" advertising. According to the Center for Science in the Public Interest, Ciba's Efidac/24 ads are deceptive because they urge "cold sufferers to rely on 24-hour, time-release Efidac/24, even though the product contains pseudoephedrine hydrochloride, which can cause sleeplessness." Ads for Nature's Plus' Source of Life dietary supplement were cited by CSPI because they claim to deliver "'an incredible burst of energy' the very first time you try it."
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC